Characterisation of peptidylprolyl isomerase C as a novel player in the pathogenesis of chronic liver disease
Por:
I. FUSTER-MARTÍNEZ, A. BENEDICTO, C. BENAVIDES, J. CATALÀ-SENENT, M. HIDALGO, F. GARCÍA-GARCÍA, J. TOSCA, C. MONTÓN, J. ESPLUGUES, N. APOSTOLOVA and A. BLAS-GARCÍA
Publicada:
1 jun 2024
Resumen:
Filiaciones:
I. FUSTER-MARTÍNEZ:
Univ Valencia, Dept Farmacol, Valencia, Spain
FISABIO Fdn Fomento Invest Sanitaria & Biomed Com, Valencia, Spain
A. BENEDICTO:
Univ Valencia, Dept Farmacol, Valencia, Spain
FISABIO Fdn Fomento Invest Sanitaria & Biomed Com, Valencia, Spain
C. BENAVIDES:
Univ Valencia, Dept Farmacol, Valencia, Spain
FISABIO Fdn Fomento Invest Sanitaria & Biomed Com, Valencia, Spain
J. CATALÀ-SENENT:
Principe Felipe Res Ctr, Bioinformat & Biostat Unit, Valencia, Spain
:
Principe Felipe Res Ctr, Bioinformat & Biostat Unit, Valencia, Spain
:
Principe Felipe Res Ctr, Bioinformat & Biostat Unit, Valencia, Spain
J. TOSCA:
Hosp Clin Univ Valencia, Dept Med Digest, Valencia, Spain
C. MONTÓN:
Hosp Clin Univ Valencia, Dept Med Digest, Valencia, Spain
J. ESPLUGUES:
Univ Valencia, Dept Farmacol, Valencia, Spain
FISABIO Fdn Fomento Invest Sanitaria & Biomed Com, Valencia, Spain
CIBERehd Ctr Invest Biomed Red Enfermedades Hepat, Valencia, Spain
N. APOSTOLOVA:
Univ Valencia, Dept Farmacol, Valencia, Spain
FISABIO Fdn Fomento Invest Sanitaria & Biomed Com, Valencia, Spain
CIBERehd Ctr Invest Biomed Red Enfermedades Hepat, Valencia, Spain
A. BLAS-GARCÍA:
FISABIO Fdn Fomento Invest Sanitaria & Biomed Com, Valencia, Spain
CIBERehd Ctr Invest Biomed Red Enfermedades Hepat, Valencia, Spain
Univ Valencia, Dept Fisiol, Valencia, Spain
|